We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
-7.13%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$131M
Cap. Flow
-$83.5M
Cap. Flow %
-38.69%
Top 10 Hldgs %
42.5%
Holding
85
New
16
Increased
22
Reduced
28
Closed
19

Top Buys

Rank Stock Value
1
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$4.88M
2
SAGE
Sage Therapeutics
SAGE
+$4.34M
3
TECX
Tectonic Therapeutic
TECX
+$4.04M
4
SDGR icon
Schrodinger
SDGR
+$3.02M
5
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
+$2.98M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$14.2M
2
BSX icon
Boston Scientific
BSX
+$12.4M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$9.42M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$8.04M
5
TFX icon
Teleflex
TFX
+$7M

Sector Composition

Rank Sector Weight
1 Healthcare 92.89%
2 Technology 1.17%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
76
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.5B
– –
-75,000
Closed -$7.13M
XNCR icon
77
Xencor
XNCR
$1.72B
– –
-25,000
Closed -$860K
ZBH icon
78
Zimmer Biomet
ZBH
$18.7B
– –
-97,850
Closed -$14.2M
CDMO
79
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-140,523
Closed -$1.08M
MYOV
80
DELISTED
Myovant Sciences Ltd.
MYOV
– –
-99,413
Closed -$1.54M
PHAS
81
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-91,091
Closed -$557K
PTLA
82
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-275,505
Closed -$6.58M
FTSV
83
DELISTED
Forty Seven, Inc. Common Stock
FTSV
– –
-40,000
Closed -$1.57M
FOMX
84
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-932,141
Closed -$3.1M
BHVN
85
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-20,000
Closed -$1.09M
1 2 3
4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Parkman Healthcare Partners held 85 positions worth $216M, down 38% from $346M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Parkman Healthcare Partners withdrew a net $83.5M in Q1 2020, closing 19 positions and reducing 28 holdings. Its most notable exit was Zimmer Biomet, an estimated $14.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Technology and Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Momenta Pharmaceuticals, Inc. worth $4.77M.

  • Parkman Healthcare Partners's largest Q1 2020 buy was Momenta Pharmaceuticals, Inc.: 175,453 shares worth $4.77M.
  • Parkman Healthcare Partners added most to Tectonic Therapeutic in Q1 2020, an estimated $4.04M increase.
  • Parkman Healthcare Partners's biggest Q1 2020 reduction was Seagen Inc. Common Stock, cutting an estimated $9.42M.
  • Parkman Healthcare Partners fully exited Zimmer Biomet in Q1 2020, selling an estimated $14.2M.
  • Parkman Healthcare Partners's ten largest holdings make up 42% of its $216M portfolio in Q1 2020.
  • Parkman Healthcare Partners opened 16 new positions and closed 19 in Q1 2020.
  • Parkman Healthcare Partners's portfolio value fell 38% quarter-over-quarter to $216M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2020, filed 15 May 2020.